12/20/2024
6:03 PM | BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
3:04 PM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
10:39 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
11/06/2024
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
6:40 AM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/14/2024
6:06 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/14/2024
5:24 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/12/2024
3:09 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:32 AM | Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:35 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:30 AM | Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2024
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:00 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:03 AM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:38 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:41 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:23 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:27 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:14 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:17 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:20 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:45 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:47 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:49 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:51 AM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:53 AM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:36 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:38 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:42 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:31 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:33 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:25 AM | Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:18 AM | Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/17/2024
6:41 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
7:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:36 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
04/16/2024
3:12 PM | Teva Pharmaceutical Industries (Filer)
| Form ARS | |
04/16/2024
3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A | |
04/09/2024
9:26 AM | Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
03/07/2024
3:27 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:27 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:57 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:48 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:52 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:54 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:40 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:43 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:45 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:37 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:42 AM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:37 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
6:49 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
7:03 AM | Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
02/01/2024
6:26 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:28 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:18 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:22 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
